Polihexanide-Perspectives on clinical wound antisepsis

Skin Pharmacology and Physiology

Volumn 23, Issue SUPPL. 1, 2010, Pages 1-3

  Kramer, A ^a   Hubner N O ^a   Assadian, O ^a   Mulder, G ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAVASEPT; PENICILLIN DERIVATIVE; POLY(HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTISEPSIS; CHRONIC WOUND; DRUG RESEARCH; EDITORIAL; INFECTION PREVENTION; PRIORITY JOURNAL; ULCER; WOUND CARE; WOUND DRESSING; WOUND INFECTION;

ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; BIGUANIDES; DRUG RESISTANCE, MICROBIAL; HUMANS; SKIN; WOUND INFECTION;

EID: 77956538471     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318899     Document Type: Editorial

References (28)

1. Jacob SE, James WD: From road rash to top allergen in a flash: bacitracin. Dermatol Surg 2004;30:521-524.
2. Gollhausen R, Enders F, Przybilla B, Burg G, Ring J: Trends in allergic contact sensitization. Contact Dermatitis 1988;18:147-154.
3. Gehrig KA, Warshaw EM: Allergic contact dermatitis to topical antibiotics: epidemiology, responsible allergens, and management. J Am Acad Dermatol 2008;58:1-21.
4. Gette MT, Marks JG, Maloney ME: Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol 1992;128:365-367.
5. Alsterholm M, Flytstrom I, Bergbrant IM, Faergemann J: Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 2010;9:52-57.
6. Kinney MA, Yentzer BA, Fleicher AB, Feld-mann SR: Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? J Drug Dermatol 2010;9:519-524.
7. Leyden JJ: Antibiotic resistance in the topical treatment of acne vulgaris. Cutis 2004; 73: 6-10.
8. Kramer A, Niedner R: Toxikologische Anforderungen an lokale Antiinfektiva; in Kramer A, Wendt M, Werner HP (eds): Moglichkeiten und Perspektiven der klinischen Antiseptik. Wiesbaden, mhp, 1995, pp 35-40.
9. Hansbrough JF, Achauer B, Dawson J, Himel H, Luterman A, Slater H, Levenson S, Salz-berg CA, Hansbrough WB, Dore C: Wound healing in partial-thickness burn wounds treated with collagenase ointment versus silver sulfadiazine cream. J Burn Care Rehabil 1995;16:241-247.
10. Hierholzer S, Hierholzer G: PVP-Iod in der operativen Medizin. Berlin, Springer, 1984.
11. Good H: Charakterisierung der Desinfek-tionsmittel. Aktuelle Probleme der Chirur-gie und Orthopadie. Bern, Huber, 1979, pp 87-96.
12. Willenegger H: Local antiseptics in surgery-revival and advance. Eur J Trauma 1994;20: 94-100.
13. Kramer A, Willenegger H: Perioperative Antibiotikaprophylaxe-dominierende Mog-lichkeit zur Infektionsprophylaxe bei chirur-gischen Eingriffen? Hyg Med 1994; 19:180-182.
14. Kramer A, Roth B, Muller G, Rudolph P, Klocker N: Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 2004; 17:141-146.
15. Wiegand C, Abel M, Kramer A, Muller G, Ruth P, Hipler U-C: Stimulation of proliferation and biocompatibility of polihexanide. GMS Krankenhaushyg Interdiszip 2007; 2:Doc43(20071228).
16. Wiegand C, Abel M, Ruth P, Hipler U: HaCaT keratinocytes in co-culture with Staphylococcus aureus can be protected from bacterial damage by polihexanide. Wound Repair Regen 2009;17:730-738.
17. Koburger T, Hubner NO, Braun M, Siebert J, Kramer A: Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010 DOI: 10.1093/jac/dkq212.
18. Kramer A, Adrian V, Rudolph P, Wurster S, Lippert H: Explantationstest mit Haut und Peritoneum der neonatalen Ratte als Voraussetzung zur Vertraglichkeit lokaler Antiinfektiva ftir Wunden und Korper-hohlen. Chirurg 1998;69:840-845.
19. Muller G, Kramer A: Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 2008;61: 1281-1287.
20. Behrens-Baumann W, Kramer A: Therapeutic indications for local anti-infectives. Anti-infectives against amebic keratitis. Dev Ophthalmol 2002;33:297-303.
21. Roth B, Assadian O, Wurmitzer F, Kramer A: Surgical site infections after primary antiseptic cleansing of dirty-contaminated wounds by polihexanide, PVP iodine resp. hydrogen peroxide. GMS Krankenhaushyg Interdiszip 2007;2:Doc58(20071228).
22. Mulder GD, Cavorsi JP, Lee DK: Polyhexa-methylene biguanide (PHMB): an addendum to current topical antimicrobials. Wounds 2007;19:173-182.
23. Kramer A, Daeschlein G, Kammerlander G, Andriessen A, Aspock C, Bergemann R Eberlein T, Gerngross H, Gortz G, Heeg P, Junger M, Koch S, KonigB, Laun R Peter RU, Roth B, Ruef C, Sellmer W, Wewalka G, Eisenbeiss W: Konsensusempfehlung zur Auswahl von Wirkstoffen fur die Wundan-tiseptik. Hyg Med 2004;29:147-157.
24. Dissemond J, Gerber V, Kramer A, Riepe G, Strohal R, Vasel-Biergans A, Eberlein T: A practice-orientated recommendation for treatment of critically colonized and locally infected wounds using polihexanide. J Wound Tech 2010;7:27-33.
25. AWMF-Leitlinien-Register Nr 029/019. Massnahmen beim Auftreten multiresisten-ter Erreger (MRE). www.uni-duesseldorf.de/AWMF/ll/029-019.htm. 2004.
26. AWMF-Leitlinien-Register Nr 037/009. Diagnostik und Therapie des Ulcus cruris venosum. www.uni-duesseldorf.de/AWMF/U/037-009.htm. 2004.
27. Gilliver S: PHMB: a well-tolerated antiseptic with no reported toxic effects. J Wound Care/ACTIVA Healthcare 2009;(suppl 2):14.
28. Barrett S, Battacharyya M, Butcher M, Enoch S, Fumarola S, Gray D, Haynes JS, Edwards-Jones V, Leaper D, Strohal R, White R Wicks G, Young T: PHMB and its potential contribution to wound management. Wounds Int 2010;1 (in press).